CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics
-
PSG ordered to pay around 60mn euros to Mbappe in wage dispute
-
BBC says will fight Trump's $10 bn defamation lawsuit
-
Stocks retreat ahead of US jobs, oil drops on Ukraine hopes
-
Suicide bomber kills five soldiers in northeast Nigeria: sources
-
EU set to drop 2035 combustion-engine ban to boost car industry
-
Australia's Green sold for record 252 mn rupees in IPL auction
-
Elusive December sun leaves Stockholm in the dark
-
Brendan Rodgers joins Saudi club Al Qadsiah
-
Thailand says Cambodia must announce ceasefire 'first' to stop fighting
-
M23 militia says to pull out of key DR Congo city at US's request
-
Thousands of glaciers to melt each year by mid-century: study
-
China to impose anti-dumping duties on EU pork for five years
-
Nepal starts tiger census to track recovery
-
Economic losses from natural disasters down by a third in 2025: Swiss Re
-
Indonesians reeling from flood devastation plea for global help
-
Timeline: How the Bondi Beach mass shooting unfolded
-
On the campaign trail in a tug-of-war Myanmar town
-
Bondi Beach suspect visited Philippines on Indian passport
-
Kenyan girls still afflicted by genital mutilation years after ban
-
Djokovic to warm up for Australian Open in Adelaide
-
Man bailed for fire protest on track at Hong Kong's richest horse race
-
Men's ATP tennis to apply extreme heat rule from 2026
-
Cunningham leads Pistons past Celtics, Nuggets outlast Rockets
-
10-year-old girl, Holocaust survivors among Bondi Beach dead
-
Steelers edge towards NFL playoffs as Dolphins eliminated
-
Australian PM says 'Islamic State ideology' drove Bondi Beach gunmen
-
Canada plow-maker can't clear path through Trump tariffs
-
Bank of Japan expected to hike rates to 30-year high
-
Cunningham leads Pistons past Celtics
-
Stokes tells England to 'show a bit of dog' in must-win Adelaide Test
-
EU to unveil plan to tackle housing crisis
-
EU set to scrap 2035 combustion-engine ban in car industry boost
-
Australian PM visits Bondi Beach hero in hospital
-
'Easiest scam in the world': Musicians sound alarm over AI impersonators
-
'Waiting to die': the dirty business of recycling in Vietnam
-
Asian markets retreat ahead of US jobs as tech worries weigh
-
Security beefed up for Ashes Adelaide Test after Bondi shooting
-
Famed Jerusalem stone still sells despite West Bank economic woes
-
Trump sues BBC for $10 billion over documentary speech edit
-
Chile follows Latin American neighbors in lurching right
-
Will OpenAI be the next tech giant or next Netscape?
-
Khawaja left out as Australia's Cummins, Lyon back for 3rd Ashes Test
-
Australia PM says 'Islamic State ideology' drove Bondi Beach shooters
-
Scheffler wins fourth straight PGA Tour Player of the Year
-
Loop Industries and Ester Industries' India Joint Venture Awards Detailed Engineering Contract to Toyo for Infinite Loop(TM) India
-
Greene Concepts Earns Keychain Preferred Partner Status, Expanding Access to 20,000+ CPG Brands
-
Lumena Intelligent Alliance Office Defines Its Financial Intelligence Framework Through Charles Winslow's Strategic Vision
-
uBriGene Launches LVV Turbo(TM) - Its Next-Generation GMP Lentiviral Vector Manufacturing Platform - and announces a Strategic Partnership with Syenex for integration of its UltraCell(TM) Technology
-
Nextech3D.ai Appoints Global Head of Sales
-
ZTEST Grants Stock Options
NYSE - LSE
CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics
TAMPA, FL / ACCESS Newswire / December 16, 2025 / (OTCQB:CTTH) CTT Pharmaceutical Holdings, Inc. is pleased to announce that a peer-reviewed scientific paper has been published in the journal of Drug Delivery and Therapeutics, authored by our scientist Dr. Katharine Cole and Dr. Pankaj Modi, the founder of CTT Pharma. The article provides the first comprehensive scientific review describing how micellar nanotechnology, when combined with an oral dissolvable strip delivery system, can significantly improve the delivery and bioavailability of active therapeutic compounds. "This review article is an important step forward in bringing wider scientific attention to this innovative and transformative technology," said Dr. Cole.
This publication is available on the Company's website www.cttpharmaceuticals.com in the 'Scientific Publications' section. This section includes peer-reviewed articles authored by CTT scientists that contribute to the broader scientific literature in areas relevant to the company's scientific focus. These publications are provided solely for transparency and informational purposes. Additional publications will be added as they become available.
CTT Pharma
813-606-0060
SOURCE: CTT Pharmaceutical Holdings, Inc.
View the original press release on ACCESS Newswire
M.A.Colin--AMWN